← Back to Search

Behavioural Intervention

Single Arm for Healthy Subjects

N/A

Recruiting

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3-month and 6-month follow-ups

Awards & highlights

Study Summary

This trial aims to study chronic low back pain (CLBP) by using brain-based biomarkers to predict symptom progression. The researchers will use electroencephalogram (EEG) neuroimaging

Who is the study for?

This trial is for adults with chronic low back pain (CLBP) who can speak English. It's not suitable for individuals with cancer, severe psychiatric conditions, those involved in injury litigation or receiving workers' compensation benefits.Check my eligibility

What is being tested?

The study tests if EEG-based biomarkers can predict the progression of CLBP symptoms. Participants will undergo EEGs to track brain activity related to resting state, emotions, and cognition at baseline and then after 3 and 6 months.See study design

What are the potential side effects?

There are no direct side effects from participating in this trial as it involves non-invasive EEG testing. However, some participants might experience discomfort from wearing the EEG cap or sitting still during the procedure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3-month and 6-month follow-ups

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3-month and 6-month follow-ups

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-month and 6-month follow-ups for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

EEG error related negativity changes from baseline

EEG late positive potential changes from baseline

EEG resting state functional connectivity changes from baseline

+1 more

Secondary outcome measures

Neuropsychological changes from baseline as assessed by the NIH toolbox

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single ArmExperimental Treatment3 Interventions

All participants will complete all interventions

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,396 Previous Clinical Trials

17,341,425 Total Patients Enrolled

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH

485 Previous Clinical Trials

1,086,769 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the clinical trial open to participants aged 85 years and older?

"Individuals aged 18 to 80 years old are eligible for enrollment in this trial."

Answered by AI

What is the current number of participants being recruited for this research endeavor?

"Indeed, the details on clinicaltrials.gov indicate that this investigation is actively seeking participants. Originally shared on December 15th, 2023, with the most recent update made on April 15th, 2024, the study aims to recruit a total of 130 patients from one specific location."

Answered by AI

Which individuals are considered the most suitable candidates for participation in this research study?

"To be eligible for enrollment, participants must fit the criteria of being in good health and aged between 18 to 80 years. The study aims to recruit approximately 130 patients."

Answered by AI

Are new participants currently being accepted for enrollment in this clinical trial?

"Indeed, as per the details on clinicaltrials.gov, this investigation is presently seeking potential participants. The trial was initially disclosed on December 15th of 2023 and had its latest update on April 15th, 2024. It aims to enroll about 130 individuals from a singular site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Detection of EEG-Based Biomarkers of Chronic Low Back Pain

Edward Lannon 2023. "Detection of EEG-Based Biomarkers of Chronic Low Back Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06025201.

All > Lower Back Pain